EU PV for Retapamulin-Prescribing
Condition(s):ImpetigoLast Updated:June 10, 2013Completed
Hide Studies Not Open or Pending
Condition(s):ImpetigoLast Updated:June 10, 2013Completed
Condition(s):ImpetigoLast Updated:April 14, 2015Terminated
Condition(s):ImpetigoLast Updated:September 23, 2016Completed
Condition(s):Lymphatic Filariases; Scabies; Impetigo; Soil Transmitted HelminthsLast Updated:December 31, 2020Completed
Condition(s):Skin and Subcutaneous Tissue Bacterial Infections; Wound Infection; Cutaneous Abscess; Burn Infection; CellulitisLast Updated:August 7, 2012Completed
Condition(s):Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary Tract InfectionsLast Updated:April 25, 2023Not yet recruiting
Condition(s):Atopic DermatitisLast Updated:June 17, 2020Completed
Condition(s):Atopic Dermatitis EczemaLast Updated:November 7, 2019Completed
Condition(s):Staphylococcus AureusLast Updated:March 23, 2012Unknown status
Condition(s):Atopic Dermatitis; EczemaLast Updated:November 5, 2020Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.